Aerovate Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Aerovate Therapeutics Inc
CIK #0001798749
EDGAR Form CIK 2011 - 2026
10-K [0001798749]
10-Q [0001798749]
3 [0001798749]
4 [0001798749]
8-K [0001798749]
D [0001798749]
SC 13D [0001798749]
SC 13G [0001798749]
Form 13D/13G Filer Form 13D/13G Subject Filed
Paradigm Biocapital Advisors LP Jade Biosciences Inc [2026-07-17]
Bellevue Group AG Jade Biosciences Inc [2026-02-17]
Janus Henderson Group PLC Jade Biosciences Inc [2026-02-17]
RA Capital Management LP Jade Biosciences Inc [2025-10-16]
Vanguard Group Inc Jade Biosciences Inc [2025-07-29]
BlackRock Inc Jade Biosciences Inc [2025-07-17]
Deep Track Capital LP Jade Biosciences Inc [2025-06-20]
FMR LLC Jade Biosciences Inc [2025-06-06]
Venrock Healthcare Capital Partners III LP Jade Biosciences Inc [2025-05-05]
Frazier Life Sciences Public Fund LP Jade Biosciences Inc [2025-05-05]
Fairmount Funds Management LLC Jade Biosciences Inc [2025-05-01]
TCG Crossover GP I LLC Aerovate Therapeutics Inc [2024-02-09]
Baker Bros Advisors LP Aerovate Therapeutics Inc [2022-02-14]
Atlas Venture Associates XII LLC Aerovate Therapeutics Inc [2021-11-05]
Sofinnova Venture Partners X LP Aerovate Therapeutics Inc [2021-07-13]
Citadel Advisors LLC Aerovate Therapeutics Inc [2021-07-12]
RA Capital Management LP Aerovate Therapeutics Inc [2021-07-12]
Cormorant Asset Management LP Aerovate Therapeutics Inc [2021-07-12]
Form 3/4/5 Subject 2011 - 2026
Jade Biosciences Inc
Eisner Mark
Lavelle Erin
Cain Christopher W
Dobmeier Eric
Klein Lawrence Otto
Kiselak Tomas
Fairmount Funds Management LLC
Harwin Peter Evan
Fairmount Healthcare Fund II LP
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Jade Biosciences Inc JBIO
Common Stock
2026-02-12 Grant 28,125 $0.00
Jade Biosciences Inc JBIO
Common Stock
2026-02-12 Grant 37,813 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 247,500 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 226,875 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 168,750 $0.00
Jade Biosciences Inc JBIO
Common Stock
2026-02-12 Grant 78,750 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 472,500 $0.00
Jade Biosciences Inc JBIO
Common Stock
2026-02-12 Grant 41,250 $0.00
Jade Biosciences Inc JBIO
Common Stock
2025-10-06 Grant 1,333,126 $9.14 12,184,772
Jade Biosciences Inc JBIO
Pre-Funded Warrant (Right to Buy) · derivative
2025-10-06 Grant 855,047 $9.14 7,815,130
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2025-07-14 Grant 526,000 $0.00
Jade Biosciences Inc JBIO
Common Stock
2025-05-16 Buy 6,000 $7.40 44,400
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2025-04-29 Grant 23,017 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2025-04-29 Grant 23,017 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2025-04-29 Grant 23,017 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2025-04-29 Grant 23,017 $0.00
Jade Biosciences Inc JBIO
Stock Option (Right to Buy) · derivative
2025-04-29 Grant 23,017 $0.00
Jade Biosciences Inc JBIO
Common Stock
2025-04-28 Other 1,062,326
Jade Biosciences Inc AVTE
Stock Option (Right to Buy) · derivative
2024-08-01 Option exercise 1,507 $0.00
Jade Biosciences Inc AVTE
Common Stock
2024-08-01 Option exercise 1,507 $1.74 2,622
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com